Biocon Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TICAGRELOR PH. EUR, with a corresponding US DMF Number 39572.
Remarkably, this DMF maintains an Active status since its submission on December 27, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 03, 2025, and payment made on December 20, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II